Galmed Pharmaceuticals Stock Forecast

Sell candidate since Jul 02, 2026 Loss -1.82%

The Galmed Pharmaceuticals Ltd. stock price fell by -1.75% on the last day (Friday, 10th Jul 2026) from $0.570 to $0.560. During the last trading day the stock fluctuated 5.17% from a day low at $0.542 to a day high of $0.570. The price has fallen in 5 of the last 10 days and is down by -2.35% for this period. Volume has increased on the last day by 11 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 25 thousand shares were bought and sold for approximately $14.24 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.50% during the next 3 months and, with a 90% probability hold a price between $0.368 and $0.545 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GLMD Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Galmed Pharmaceuticals Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.578 and $0.604. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -13.55%. Further fall is indicated until a new bottom pivot has been found. Galmed Pharmaceuticals Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Galmed Pharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.525 and $0.522. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Galmed Pharmaceuticals Ltd. finds support just below today's level at $0.525. If this is broken, then the next support from accumulated volume will be at $0.522 and $0.469.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0280 between high and low, or 5.17%. For the last week, the stock has had daily average volatility of 5.13%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLMD) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Galmed Pharmaceuticals Ltd. to open at $0.557, and during the day (based on 14 day Average True Range), to move between $0.533 and $0.587, which gives a possible trading interval of +/-$0.0537 (+/-10.08%) up or down from last closing price. If Galmed Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 10.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.564 (0.73%) than the support at $0.525 (6.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Galmed Pharmaceuticals Ltd. stock A Buy?

Galmed Pharmaceuticals Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.425 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.557 ( 0.476%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk